Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rivka Litvin"'
Autor:
Gabriela S. Hobbs, Amritha Varshini Hanasoge Somasundara, Maria Kleppe, Rivka Litvin, Maria Arcila, Jihae Ahn, Anna Sophia McKenney, Kristina Knapp, Ryan Ptashkin, Howard Weinstein, Murk-Hein Heinemann, Jasmine Francis, Suzanne Chanel, Ellin Berman, Michael Mauro, Martin S. Tallman, Mark L. Heaney, Ross L. Levine, Raajit K. Rampal
Publikováno v:
Haematologica, Vol 103, Iss 1 (2018)
Externí odkaz:
https://doaj.org/article/562c84fe1892430fb07bda7a916c5530
Autor:
Gilad J Regev, Roi Treister, Silviu Brill, Dror Ofir, Khalil Salame, Zvi Lidar, Morsi Khashan, Rivka Litvin, Uri Hochberg
Publikováno v:
Journal of Pain Research. 16:933-941
Gilad J Regev,1,2 Roi Treister,3 Silviu Brill,2,4 Dror Ofir,1,2 Khalil Salame,1,2 Zvi Lidar,1,2 Morsi Khashan,1,2 Rivka Litvin,5 Uri Hochberg2,4 1Spine Surgery Unit, Neurosurgical Department, Tel Aviv Medical Center, Tel Aviv, Israel; 2Sackler School
Autor:
Ross L. Levine, Caroline J McNamara, Damiano Rondelli, Rona Singer Weinberg, Andrew T. Kuykendall, Christopher Famulare, Molly Maloy, Rivka Litvin, Ruben A. Mesa, Rami S. Komrokji, Andrea Arruda, David A. Sallman, Minal Patel, Lonette Sandy, Juan Medina, Amylou C. Dueck, Ronald Hoffman, Vesna Najfeld, Roni Tamari, Franck Rapaport, Hugo Castro-Malaspina, Raajit K. Rampal, Nan Zhang, Vikas Gupta, Sergio Giralt, John Mascarenhas
Publikováno v:
Biol Blood Marrow Transplant
Mutational profiling has demonstrated utility in predicting the likelihood of disease progression in patients with myelofibrosis (MF). However, there is limited data regarding the prognostic utility of genetic profiling in MF patients undergoing allo
Autor:
Martin S. Tallman, Maria E. Arcila, Ross L. Levine, Gabriella Hobbs, Anna Sophia McKenney, Amritha Varshini Hanasoge Somasundara, Jihae Ahn, Ellin Berman, Suzanne Chanel, Jasmine H. Francis, Kristina M. Knapp, Ryan Ptashkin, Murk-Hein Heinemann, Maria Kleppe, Howard J. Weinstein, Rivka Litvin, Raajit K. Rampal, Mark L. Heaney, Michael J. Mauro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be920731ccdeaf7c22916e09b9b508d1
https://europepmc.org/articles/PMC5777196/
https://europepmc.org/articles/PMC5777196/
Autor:
Molly Maloy, Franck Rapaport, John Mascarenhas, Vikas Gupta, Sergio Giralt, Damiano Rondelli, Amylou C. Dueck, Caroline J McNamara, Ronald Hoffman, Rona Singer Weinberg, Rivka Litvin, Nan Zhang, Ruben A. Mesa, Roni Tamari, Ross L. Levine, Hugo Castro-Malaspina, Raajit K. Rampal
Publikováno v:
Blood. 128:2301-2301
Introduction: The impact of genomic alterations, such as mutations in ASXL1, on the risk of disease progression and leukemic transformation in patients with myelofibrosis (MF) is well established. Further, emerging data suggests that the number and t